These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 9452429

  • 1. Amino acid analogs activate NF-kappaB through redox-dependent IkappaB-alpha degradation by the proteasome without apparent IkappaB-alpha phosphorylation. Consequence on HIV-1 long terminal repeat activation.
    Kretz-Remy C, Bates EE, Arrigo AP.
    J Biol Chem; 1998 Feb 06; 273(6):3180-91. PubMed ID: 9452429
    [Abstract] [Full Text] [Related]

  • 2. The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of Ikappa B.
    Bour S, Perrin C, Akari H, Strebel K.
    J Biol Chem; 2001 May 11; 276(19):15920-8. PubMed ID: 11278695
    [Abstract] [Full Text] [Related]

  • 3. Hiv-1 Tat can substantially enhance the capacity of NIK to induce IkappaB degradation.
    Li X, Josef J, Marasco WA.
    Biochem Biophys Res Commun; 2001 Aug 24; 286(3):587-94. PubMed ID: 11511100
    [Abstract] [Full Text] [Related]

  • 4. Proteasome-independent activation of nuclear factor kappaB in cytoplasmic extracts from human endothelial cells by Rickettsia rickettsii.
    Sahni SK, Van Antwerp DJ, Eremeeva ME, Silverman DJ, Marder VJ, Sporn LA.
    Infect Immun; 1998 May 24; 66(5):1827-33. PubMed ID: 9573057
    [Abstract] [Full Text] [Related]

  • 5. NFkappa B-dependent transcriptional activation during heat shock recovery. Thermolability of the NF-kappaB.Ikappa B complex.
    Kretz-Remy C, Munsch B, Arrigo AP.
    J Biol Chem; 2001 Nov 23; 276(47):43723-33. PubMed ID: 11559696
    [Abstract] [Full Text] [Related]

  • 6. Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity.
    Yin L, Laevsky G, Giardina C.
    J Biol Chem; 2001 Nov 30; 276(48):44641-6. PubMed ID: 11572859
    [Abstract] [Full Text] [Related]

  • 7. A caspase-3-like protease is involved in NF-kappaB activation induced by stimulation of N-methyl-D-aspartate receptors in rat striatum.
    Qin Z, Wang Y, Chasea TN.
    Brain Res Mol Brain Res; 2000 Sep 15; 80(2):111-22. PubMed ID: 11038244
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. NO inhibits cytokine-induced iNOS expression and NF-kappaB activation by interfering with phosphorylation and degradation of IkappaB-alpha.
    Katsuyama K, Shichiri M, Marumo F, Hirata Y.
    Arterioscler Thromb Vasc Biol; 1998 Nov 15; 18(11):1796-802. PubMed ID: 9812920
    [Abstract] [Full Text] [Related]

  • 10. Tumor necrosis factor alpha induces expression of genes for matrix degradation in human chondrocyte-like HCS-2/8 cells through activation of NF-kappaB: abrogation of the tumor necrosis factor alpha effect by proteasome inhibitors.
    Sakai T, Kambe F, Mitsuyama H, Ishiguro N, Kurokouchi K, Takigawa M, Iwata H, Seo H.
    J Bone Miner Res; 2001 Jul 15; 16(7):1272-80. PubMed ID: 11450703
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of IkappaB-alpha and IkappaB-beta proteolysis by calpain inhibitor I blocks nitric oxide synthesis.
    Milligan SA, Owens MW, Grisham MB.
    Arch Biochem Biophys; 1996 Nov 15; 335(2):388-95. PubMed ID: 8914937
    [Abstract] [Full Text] [Related]

  • 12. 4-Hydroxynonenal prevents NF-kappaB activation and tumor necrosis factor expression by inhibiting IkappaB phosphorylation and subsequent proteolysis.
    Page S, Fischer C, Baumgartner B, Haas M, Kreusel U, Loidl G, Hayn M, Ziegler-Heitbrock HW, Neumeier D, Brand K.
    J Biol Chem; 1999 Apr 23; 274(17):11611-8. PubMed ID: 10206970
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. IkappaB kinase-independent IkappaBalpha degradation pathway: functional NF-kappaB activity and implications for cancer therapy.
    Tergaonkar V, Bottero V, Ikawa M, Li Q, Verma IM.
    Mol Cell Biol; 2003 Nov 23; 23(22):8070-83. PubMed ID: 14585967
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The carboxy-terminus of I kappaB alpha determines susceptibility to degradation by the catalytic core of the proteasome.
    Kroll M, Conconi M, Desterro MJ, Marin A, Thomas D, Friguet B, Hay RT, Virelizier JL, Arenzana-Seisdedos F, Rodriguez MS.
    Oncogene; 1997 Oct 09; 15(15):1841-50. PubMed ID: 9362451
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.